Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 17/04/20121 min de leitura
Withdrawal of Approval of Part of a New Animal Drug Application; Tiamulin
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is withdrawing approval of those parts of a new animal drug application (NADA) for a tiamulin Type A medicated article that pertain to the production indications for use of increased rate of weight gain and improved feed efficiency in swine. This action is being taken at the sponsor's request because this product is no longer marketed for these uses.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →